JCR Pharmaceuticals Co., Ltd.
4552.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥79 | ¥63 | ¥60 | ¥75 |
| - Cash | ¥16 | ¥13 | ¥13 | ¥16 |
| + Debt | ¥40 | ¥40 | ¥38 | ¥32 |
| Enterprise Value | ¥103 | ¥89 | ¥85 | ¥92 |
| Revenue | ¥13 | ¥9 | ¥7 | ¥9 |
| % Growth | 49.3% | 19.1% | -22% | – |
| Gross Profit | ¥11 | ¥6 | ¥3 | ¥7 |
| % Margin | 84.3% | 72.1% | 39.2% | 71% |
| EBITDA | ¥4 | ¥0 | -¥5 | ¥1 |
| % Margin | 32% | 0.8% | -72% | 8% |
| Net Income | ¥2 | -¥1 | -¥4 | ¥0 |
| % Margin | 17.6% | -6.4% | -58.2% | 1.2% |
| EPS Diluted | 18.5 | -4.48 | -33.8 | 0.94 |
| % Growth | 512.9% | 86.7% | -3,695.7% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |